May 06, 2019
Amarin Pharma Inc. on Monday announced legal settlements with two dietary supplement sellers that allegedly hijacked results from the drugmaker's high-profile study of omega-3 fatty acids, adding that it has attorneys "on speed dial" to sue other supplement makers if needed.
October 30, 2018
Amarin Pharma Inc. has accused two supplement makers in California federal court of undercutting the reputation of its U.S. Food and Drug Administration-approved medication Vascepa by relying on its clinical trial to prove that their own omega-3 products have cardiovascular benefits.